期刊文献+

基于狂犬病病毒G蛋白scFv介导的靶向shRNA制备与鉴定 被引量:3

Targeted inhibition of Rabies Virus replication in vitro by single chain antibody domain mediated vector expression shRNA delivery
原文传递
导出
摘要 【目的】探讨以狂犬病病毒G糖蛋白单链抗体介导的载体表达shRNA靶向制剂,靶向抑制狂犬病毒复制的可行性。【方法】应用PCR技术获得狂犬病毒G糖蛋白单链抗体scFv(G)和绿脓杆菌跨膜区-酵母DNA结合结构域ETA-GAL4基因,通过搭桥PCR法获得scFv(G)-ETA-GAL4(SEG)嵌合基因;克隆至原核表达载体pET28a(+),构建重组表达质粒pET28a(+)-scFv(G)-ETA-GAL4(pET28a-SEG);在大肠杆菌BL21(DE3)中经IPTG诱导表达,利用镍柱亲和层析法纯化包涵体,经复性、鉴定制得SEG蛋白;ELISA法检测表达蛋白与狂犬病毒特异结合活性;将SEG蛋白与含shRNA的质粒(pRNATU6.3-shRNA)连接制成靶向shRNA,接入100 TCID50狂犬病毒感染BHK-21细胞,35 h观察细胞中绿色荧光蛋白(GFP)表达情况;48 h用直接免疫荧光抗体试验测定复合物抑制病毒效果。【结果】克隆得到1557 bp的SEG蛋白编码基因,大肠杆菌中成功表达57 KDa的SEG蛋白,能与抗His的单克隆抗体发生特异性反应,SEG蛋白经镍柱纯化、复性后得率为2.8 mg/mL。ELISA试验证明SEG蛋白在一定浓度范围内与RV结合呈正相关。细胞试验表明GFP在细胞内得到表达;直接免疫荧光试验测定该复合物能抑制76%病毒复制。【结论】SEG蛋白能与携带shRNA的质粒结合,可运送该质粒至RV感染BHK-21细胞中,抑制狂犬病毒的复制。 [ Objective] Single chain antibody-mediated delivery is a novel approach for targeting shRNA to appropriate cells. In this report, we studied whether this shRNA delivery strategy would be effective against rabies virus. [ Methods] Rabies virus scFv (G) gene and ETA-GAIA gene were amplified by PCR from vector seFv (G)-T and PE40-GAL4-T respectively. Then, the chimeric gene scFv(G)-ETA-GAL4 was constructed by lapextension PCR and cloned into the prokaryotie expression vector pET28a( + ). Recombinant expression plasmid of pET28a ( + )-seFv (G)-ETA-GAIA was constructed and then transformed into the competent E. coli BL21 ( DE3 ) cells for expression under the induction of IPTG. scFv(G) -ETA-GAIA protein was purified by Ni-NTA His Bind Resin affinity chromatograph and identified by SDS-PAGE gel and Western blot assay. Binding of the fusion protein scFv(G)-ETA-GAL4 to rabies virus was determined by ELISA. Complexes which formed spontaneously by the fusion protein scFv (G)-ETA-GAL4 with plasmid pRNATU6.3-shRNA were added to BHK-21 cells culture medium that infected with RV. Green fluorescent protein (GFP) was observed after 35 h and judged the transferring efficiency of the complexes. The inhibition of RV replication by shRNA was detected by direct immune fluorescence test. [Results] A 1557 bp DNA encoding scFv( G)-ETA-GAIA protein gene was cloned and successfully expressed in inclusion body with approximate molecular weight of 57.0 kDa, which could be recognized by anti-His mAb. The seFv(G)-ETA-GAlA proteins were purified by Ni-NTA column , and after renatured with the yield of 2.8 mg/mL. The ELISA results showed that when concentration of the scFv (G)-ETA-GAL4 protein ranging from 2.8 nmol/L to 1000 nmol/L, binding affinity is directly related with RV. The GFP expressed in BHK-21 cell after transfection with the complexes and effectively inhibited RV replication in BHK-21 cell. [ Conclusion ] scFv (G)-ETA- GAIA fusion protein could mediated plasmid pRNATU6.3-shRNA transferred into BHK-21 cell infected with RV, and then inhibited RV replication.
出处 《微生物学报》 CAS CSCD 北大核心 2010年第2期256-262,共7页 Acta Microbiologica Sinica
基金 国家“863”计划(2006AA02Z456) 农业公益性行业项目(200803014)~~
关键词 狂犬病毒 单链抗体 绿脓杆菌外毒素跨膜区 基因运送 SHRNA rabies virus single chain antibody pseudomonas exotoxin A translocation domain gene delivery shRNA
  • 相关文献

参考文献19

  • 1Jackson AC, Wunner WH. Rabies. 2^nd ed. London: Academic Press, 2007, 324.
  • 2Centers for Disease Control and Prevention. Human rabies prevention-United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 1999, 48(No, RR-1), 1-21.
  • 3Murphy FA , Bauer SP, Harrison AK, et al. Comparative pathogenesis of rabies and rabies-like viruses. Viral infection and transit from inoculation site to the central nervous system. Laboratory investigation; a journal of technical methods and pathology, 1973, 28 (3) : 361- 376.
  • 4Dietzschold B, Kao M, Zheng YM, et al. Delineation of putative mechanisms involved in antibody - mediated clearance of rabies virus from the central nervous system. Proceedings of the National Academy of Sciences of the United States of America, 1992, 89( 15 ) : 7252-7256.
  • 5Bosher JM, Labouesse M. RNA interference: genetic wand and genetic watchdog. Nature Cell Biology, 2000, 2(2) : E31-E36.
  • 6Tusehl T, Borkhardt A. Small interfering RNAs: revolutionary tool for the analysis of gene function and gene therapy. Molecular Interventions, 2002, 2 ( 3 ) :158-167.
  • 7Qin XF, An DS, Chen IS, et al. Inhibiting HIV-1 Infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proceedings of the National Academy of Sciences of the United States of America, 2003, 100(1) : 183-188.
  • 8Radhakrishnan SK, Layden TJ, Gartel AL, et al. RNA interference as a new strategy against viral hepatitis. Virology, 2004, 323(2): 173-181.
  • 9Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001, 411 (6836) : 494-498.
  • 10Wels W, Biburger M, Muller T , et al. Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors. Cancer Immunology Immunotherapy , 2004, 53(3) : 217-226.

二级参考文献11

  • 1王铁东,张守峰,扈荣良,郭建顺.狂犬病病毒口服疫苗株SRV_9基因组全长cDNA的克隆及特性分析[J].中国兽医学报,2005,25(4):368-370. 被引量:9
  • 2Julia M B,Michel L.RNA interference:genetic wand and genetic watchdog[J].Nature Cell Biology,2000,2:E31-E36.
  • 3Ill C R,Chiou H C.Gene therapy progress and prospects:Recent progress in transgene and RNAi expression cassettes[J].Gene Therapy,2005,10:795-802.
  • 4Prawitt D,Brixel L,Spangenberg C,et al.RNAi knock-down mice:an emerging technology for post-genomic functional genetics[J].Cytogenetic and Genome Research,2004,(2-4):412-421.
  • 5Martinez M A,Clotet B,Este J A.RNA interference of HIV replication[J].Trends in Immunology,2002,12:559-561.
  • 6Takanori Y,Naoya S,Nobuyuki E,et al.Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs[J].EMBO Reports,2003,6:602-608.
  • 7Moore M D,McGarvey M J,Russell R A,et al.Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors[J].J Gene Med,2005,7:918-925.
  • 8Anton P M,Hiroyuki N,Kusum P,et al.Inhibition of hepatitis B virus in mice by RNA interference[J].Nature Biotechnology,2003,6:639-645.
  • 9Ni B,Shi X,Li Y,et al.Inhibition of replication and infection of severe acute respiratory syndrome-associated coronavirus with plasmid-mediated interference RNA[J].Antiviral Therapy,2005,4:527-533.
  • 10Chen W,Liu M,Jiao Y,et al.Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo[J].J Virol,2006,7:3559-3566.

共引文献5

同被引文献50

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部